American Century Companies Inc. Grows Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

American Century Companies Inc. lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 143.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,051 shares of the company's stock after buying an additional 5,339 shares during the period. American Century Companies Inc. owned about 0.06% of U.S. Physical Therapy worth $803,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. grew its stake in shares of U.S. Physical Therapy by 29.5% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 4,883 shares of the company's stock valued at $433,000 after buying an additional 1,112 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its position in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares during the last quarter. Natixis Advisors LLC increased its stake in U.S. Physical Therapy by 18.4% in the 4th quarter. Natixis Advisors LLC now owns 27,346 shares of the company's stock worth $2,426,000 after purchasing an additional 4,246 shares during the period. Avantax Advisory Services Inc. lifted its position in U.S. Physical Therapy by 19.4% in the fourth quarter. Avantax Advisory Services Inc. now owns 7,591 shares of the company's stock valued at $673,000 after purchasing an additional 1,236 shares during the last quarter. Finally, HighTower Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 2.5% during the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock valued at $429,000 after purchasing an additional 119 shares during the period.

U.S. Physical Therapy Stock Down 0.5 %

Shares of NYSE USPH traded down $0.33 during trading on Thursday, reaching $68.13. The company had a trading volume of 13,250 shares, compared to its average volume of 105,667. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $108.14. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business's 50-day moving average is $77.24 and its 200 day moving average is $85.00. The stock has a market cap of $1.03 billion, a PE ratio of 72.38, a P/E/G ratio of 3.54 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 14th were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a yield of 2.64%. U.S. Physical Therapy's dividend payout ratio is 97.83%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.70% of the company's stock.

Analyst Ratings Changes

USPH has been the topic of a number of recent analyst reports. Barrington Research cut their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Thursday. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. cut their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.